TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

5.07
Delayed Data
As of Feb 27
 -0.27 / -5.06%
Today’s Change
3.42
Today|||52-Week Range
9.01
+13.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues2.9M2.8M3.8M4.2M
 
 
 
 
 
Cost of Goods Sold467.2K830.7K893.0K1.1M
 
 
 
 
 
Depreciation And Amortization7.2K13.1K14.1K12.7K
 
 
 
 
 
 
Operating ExpensesGross Income2.4M2.0M2.8M3.1M
 
 
 
 
 
General Expenses10.4M10.9M13.8M21.0M
 
 
 
 
 
Research And Development5.8M5.9M8.2M14.9M
 
 
 
 
 
Total Operating Expenses10.9M11.8M14.7M22.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.0M-9.0M-10.9M-17.8M
 
 
 
 
 
Extraordinary Credit28.9K0.000.000.00
 
 
Interest Expense On Debt396.0K260.0K0.000.00
 
 
 
Other Expenses19.1K18.6K18.6K6.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.4M-9.2M-10.9M-17.8M
 
 
 
 
 
Net Income-8.4M-9.2M-10.9M-17.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS145.0M145.0M145.5M152.2M
 
 
 
 
 
Shares To Calculate EPS Diluted145.0M145.0M145.5M152.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.06-$0.07-$0.12
 
 
 
 
 
EPS Diluted-$0.06-$0.06-$0.07-$0.12
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account